These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 32087949)
1. Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington's Disease. Ellis N; Tee A; McAllister B; Massey T; McLauchlan D; Stone T; Correia K; Loupe J; Kim KH; Barker D; Hong EP; Chao MJ; Long JD; Lucente D; Vonsattel JPG; Pinto RM; Elneel KA; Ramos EM; Mysore JS; Gillis T; Wheeler VC; Medway C; Hall L; Kwak S; Sampaio C; Ciosi M; Maxwell A; Chatzi A; Monckton DG; Orth M; Landwehrmeyer GB; Paulsen JS; Shoulson I; Myers RH; van Duijn E; Rickards H; MacDonald ME; Lee JM; Gusella JF; Jones L; Holmans P Biol Psychiatry; 2020 May; 87(9):857-865. PubMed ID: 32087949 [TBL] [Abstract][Full Text] [Related]
2. Cognitive Control, Learning, and Clinical Motor Ratings Are Most Highly Associated with Basal Ganglia Brain Volumes in the Premanifest Huntington's Disease Phenotype. Misiura MB; Lourens S; Calhoun VD; Long J; Bockholt J; Johnson H; Zhang Y; Paulsen JS; Turner JA; Liu J; Kara B; Fall E; J Int Neuropsychol Soc; 2017 Feb; 23(2):159-170. PubMed ID: 28205498 [TBL] [Abstract][Full Text] [Related]
3. Negative symptoms in Huntington's disease. Soliveri P; Paridi D; Del Sorbo F; Tramacere I; Girotti F Neurol Sci; 2022 Jun; 43(6):3695-3701. PubMed ID: 35067828 [TBL] [Abstract][Full Text] [Related]
4. Early-Motor Phenotype Relates to Neuropsychiatric and Cognitive Disorders in Huntington's Disease. Julayanont P; Heilman KM; McFarland NR Mov Disord; 2020 May; 35(5):781-788. PubMed ID: 31922295 [TBL] [Abstract][Full Text] [Related]
5. Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease. McAllister B; Gusella JF; Landwehrmeyer GB; Lee JM; MacDonald ME; Orth M; Rosser AE; Williams NM; Holmans P; Jones L; Massey TH; Neurology; 2021 May; 96(19):e2395-e2406. PubMed ID: 33766994 [TBL] [Abstract][Full Text] [Related]
6. Psychiatric and cognitive symptoms in Huntington's disease are modified by polymorphisms in catecholamine regulating enzyme genes. Vinther-Jensen T; Nielsen TT; Budtz-Jørgensen E; Larsen IU; Hansen MM; Hasholt L; Hjermind LE; Nielsen JE; Nørremølle A Clin Genet; 2016 Mar; 89(3):320-7. PubMed ID: 26081309 [TBL] [Abstract][Full Text] [Related]
7. Acute psychosis in a verified Huntington disease gene carrier with subtle motor signs: psychiatric criteria should be considered for the diagnosis. Nagel M; Rumpf HJ; Kasten M Gen Hosp Psychiatry; 2014; 36(3):361.e3-4. PubMed ID: 24576988 [TBL] [Abstract][Full Text] [Related]
9. A Genetic Study of Psychosis in Huntington's Disease: Evidence for the Involvement of Glutamate Signaling Pathways. Tsuang DW; Greenwood TA; Jayadev S; Davis M; Shutes-David A; Bird TD J Huntingtons Dis; 2018; 7(1):51-59. PubMed ID: 29480208 [TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic characteristics in patients with Huntington's disease from China. Yang J; Chen K; Wei Q; Chen Y; Cao B; Burgunder JM; Shang HF Neurol Res; 2016 Oct; 38(10):916-20. PubMed ID: 27483361 [TBL] [Abstract][Full Text] [Related]
11. Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY). van Duijn E; Craufurd D; Hubers AA; Giltay EJ; Bonelli R; Rickards H; Anderson KE; van Walsem MR; van der Mast RC; Orth M; Landwehrmeyer GB; J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1411-8. PubMed ID: 24828898 [TBL] [Abstract][Full Text] [Related]